Stoke TherapeuticsNASDAQ: STOK: Develops RNA-based therapies for severe genetic disorders.
10+ YOE5+ Mgmt10+ years CMC experience with drug-device combination products, 5+ years CMC leadership, bachelor's required (advanced degree preferred), deep CMC/regulatory knowledge, strong communication and cross-functional leadership.
Rhythm PharmaceuticalsNASDAQ: RYTM: Develops precision medicines for rare neuroendocrine and obesity diseases.
10+ YOEBS in life sciences, 10+ years regulatory CMC or related pharma experience, experience with peptides and injectable dosage forms, ability to author CMC submissions and coordinate cross-functional inputs.
Genetix Biotherapeutics: Developing and commercializing curative gene therapies for rare diseases.
10+ YOE10+ years biopharma CMC regulatory experience for biologics/gene therapies; bachelor’s or master’s in life sciences; experience with post-approval CMC submissions, GMP and global regulatory frameworks; strong communication and cross-functional skills.
SanofiEuronext Paris: SAN: Researches, develops, and manufactures medicines and vaccines globally.
5+ YOEPhD or MS in pharmaceutical-related field; minimum 5 years CMC development experience; proven CMC dossier authoring; knowledge of regulatory and digital transformation in pharma; leadership and collaboration skills; Vault RIM, Word and Adobe proficiency.
New York City or Salt Lake City or London or Montréal or Milton Park or Boston or San Francisco
$208k-$281k/yrRemoteFull Time
RecursionNASDAQ: RXRX: Developing medicines using an AI-native drug discovery platform.
8+ YOE8+ years CMC regulatory experience for small molecules, BA/BS or advanced degree, RAC preferred, deep knowledge of US, EU and ex-US CMC regulations, track record authoring INDs/NDAs, cross-functional collaboration.
AstraZenecaLondon Stock Exchange: AZN: Researches and develops medicines to treat major diseases globally.
7+ YOE7+ years pharmaceutical/biopharma CMC development and manufacturing experience; Bachelor\u0002s required (advanced degree preferred); IND-enabling and process/analytical development experience; cross-functional leadership and strategic decision-making.
Vor BioNASDAQ: VOR: Developing targeted therapies for chronic autoimmune diseases.
8+ YOEDoctorate preferred; ≥8 years Regulatory CMC biologics experience with FDA sCDER interactions, global submissions, lifecycle management, and biologics/combination product development.
AbbVieNYSE: ABBV: Develops and sells innovative pharmaceutical and biopharmaceutical medicines.
10+ YOE3+ MgmtBachelor's in pharmacy/biology/chemistry/engineering required; 10+ years biopharma experience with 3+ years enterprise leadership and 5+ years RA exposure; experience developing global regulatory CMC strategies and interfacing with agencies.
ModernaNasdaq: MRNA: Develops and manufactures messenger RNA medicines and vaccines.
15+ YOEDegree in life sciences or related field, 15 years relevant experience (or 10 years with PhD), deep stability science and CMC judgment, experience with stability strategy, regulatory submissions, leadership and cross-functional collaboration.
Xenon PharmaceuticalsNASDAQ: XENE: Developing therapeutics for neurological and psychiatric disorders.
10+ YOEPhD in Chemistry or Chemical Engineering with 10+ years API CDMO experience; regulatory CMC writing; CDMO selection and tech transfer; extensive cGMP knowledge.
CRISPR TherapeuticsNASDAQ: CRSP: Develops gene-editing medicines using the CRISPR/Cas9 platform.
12+ YOEBachelor's in relevant science required; 12+ years regulatory CMC experience (10+ with advanced degree); direct CMC experience for biologics/cell & gene therapies; knowledge of FDA/EMA/ICH and eCTD submissions.
Oruka TherapeuticsNASDAQ: ORKA: Develops long-acting biologics for chronic skin and inflammatory diseases.
6+ YOEMaster's or PhD in life sciences, 6+ years CMC experience with minimum 3+ years regulatory CMC in biologics, cGMP and global regulatory submission expertise (FDA/EMA/ICH), experience authoring Module 3 and combination product submissions.
Rapport TherapeuticsNASDAQ: RAPP: Developing precision medicines for neurological and psychiatric disorders.
12+ YOEBachelor’s degree in a scientific discipline and 12+ years of Regulatory CMC experience in biotech or pharma, including global registration, submissions, health authority interactions, and cross-functional leadership.
FDA, EMA, ICH, INDs, IMPDs, NDA, MAA, CTD Module 3
Madrigal PharmaceuticalsNASDAQ: MDGL: Develops and commercializes therapeutics for metabolic dysfunction-associated steatohepatitis.
12+ YOEBS in life sciences or equivalent experience (advanced degree preferred); minimum 12 years relevant experience with 8-10 years regulatory CMC experience; strategic CMC regulatory expertise; experience with global health authorities; strong communication and negotiation skills.
AstraZenecaLondon Stock Exchange: AZN: Global biopharmaceutical developing and manufacturing prescription medicines.
7+ YOE7+ years pharmaceutical product development and manufacturing experience; Bachelor's degree required (advanced degree preferred); IND-enabling CMC, process and analytical development, project leadership, cross-functional collaboration.
Cambridge or Research Triangle Park or San Francisco
$204k-$281k/yrHybridFull Time
BiogenNASDAQ: BIIB: Develops therapies for neurological and neurodegenerative diseases.
12+ YOE12+ years' experience in matrix leadership with CMC/supply chain or life cycle management; BS required, advanced degree preferred; alliance and financial management experience; strong strategic, communication and risk-management skills.
Associate Director / Director, CMC Project Management
Waltham, Massachusetts, United States
$220k-$245k/yrOnsiteFull Time
Korsana BiosciencesNASDAQ: CYCN: Develops novel therapies to treat neurodegenerative diseases.
8+ YOE5+ MgmtBachelor's in a scientific field required (advanced preferred); 8+ years biotech/pharma experience with ≥5 years CMC project management; experience with biologics, CDMOs, regulatory CMC familiarity; strong project and stakeholder management skills.
Crescent BiopharmaNASDAQ: CBIO: Develops novel oncology therapies and antibody-drug conjugates for cancer.
12+ YOE12+ years regulatory affairs CMC experience in pharma/biotech, advanced scientific degree required, strong regulatory negotiation and submission experience (INDs/BLAs/MAAs), leadership and communication skills.
Beam TherapeuticsNASDAQ: BEAM: Develops precision genetic medicines using base editing technology.
10+ YOEAdvanced degree in life sciences or engineering,10+ years CMC development experience with leadership, expertise in nucleic acid/LNP manufacturing and analytics, regulatory submission experience, strong risk management and communication skills.
Alnylam PharmaceuticalsNASDAQ: ALNY: Develops RNAi therapeutics to treat rare and common diseases.
8+ YOEAdvanced degree in a relevant scientific discipline, 8+ years industry experience including 5+ years in Regulatory Affairs CMC, experience with regulatory submissions and health authority interactions, strong communication and cross-functional leadership.